|

Erbitux (Cetuximab) Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • University of Campania Luigi Vanvitelli1
  • Gruppo Oncologico Italia Meridionale1

Indications

  • Cancer2
  • Metastatic Colorectal Cancer (CRC)1
  • Metastatic Colorectal Cancer (mCRC)1

Other2 trials

Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
Phase 3
ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.